Abbott Laboratories vs UnitedHealth Group Incorporated at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | ABT | UNH |
|---|---|---|
| Market cap | $203.36B | $361.28B |
| Price | $116.13 | $396.59 |
| P/E ratio (TTM) | 33.47 | 24.76 |
| P/B ratio (MRQ) | 4.19 | 3.17 |
| P/S ratio (TTM) | 4.93 | 0.67 |
| Revenue growth (1Y) | 5.67% | 11.81% |
| Return on equity (TTM) | 12.51% | 12.81% |
| Return on invested capital (TTM) | 9.36% | 9.58% |
| Gross margin (TTM) | 56.80% | 22.49% |
| Net margin (TTM) | 11.65% | 3.14% |
| Dividend yield (TTM) | 2.16% | 2.33% |
How they differ
UnitedHealth Group Incorporated is the larger company at $361.28B versus $203.36B — about 1.8x the size.
On trailing earnings, UnitedHealth Group Incorporated is the cheaper of the two at 24.76 against 33.47 for Abbott Laboratories.
On sales, UnitedHealth Group Incorporated is the cheaper of the two at 0.67 against 4.93 for Abbott Laboratories.
UnitedHealth Group Incorporated leads on revenue growth over the past year, 11.81% against 5.67%.
UnitedHealth Group Incorporated leads on return on invested capital, 9.58% against 9.36%.
Abbott Laboratories leads on gross margin, 56.80% against 22.49%.
UnitedHealth Group Incorporated offers the higher yield at 2.33% against 2.16%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving Abbott Laboratories or UnitedHealth Group Incorporated.